METHYLPHENIDATE HYDROCHLORIDE | N021284 | SANDOZ INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from KVK-Tech, Inc. (Abhai, LLC) FDA-2017-P-2496 · 5 docket documents Abhai, LLC filed this citizen petition requesting the FDA to determine whether Ritalin LA (methylphenidate hydrochloride) Extended-Release Capsules 60 mg, NDA 021284, held by Novartis Pharmaceuticals Corporation, was voluntarily withdrawn from the commercial market for safety or effectiveness reason | 505(q) | 2017-04-20 | Granted | KVK-Tech, Inc. (Abhai, LLC) |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$12.73
per ea
Lowest NADAC/Unit
$1.87
per ea
Brand NDCs
4
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00078037205RITALIN LA 40 MG CAPSULE | $12.73 | EA | Brand | $2.19 | 2025-10-22 |
| 00078037105RITALIN LA 30 MG CAPSULE | $12.39 | EA | Brand | $2.03 | 2025-10-22 |
| 00078037005RITALIN LA 20 MG CAPSULE | $12.10 | EA | Brand | $1.87 | 2025-10-22 |
| 00078042405RITALIN LA 10 MG CAPSULE | $12.07 | EA | Brand | $2.39 | 2025-09-17 |
| 00781236101METHYLPHENIDATE ER(LA) 10 MG CP | $2.39 | EA | Generic | — | 2026-06-17 |
| 00781238301METHYLPHENIDATE ER(LA) 10 MG CP | $2.39 | EA | Generic | — | 2026-06-17 |
Showing 6 of 12 NDCs.
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.